https://nl.marketscreener.com/koers/aandeel/NABRIVA-THERAPEUTICS-PLC-37853840/nieuws/Nabriva-Therapeutics-plc-kondigt-aan-dat-eerste-patient-is-ingeschreven-in-Fase-1-studie-van-Xenlet-40031506/?utm_source=telegram&utm_medium=social&utm_campaign=share